212 related articles for article (PubMed ID: 19083227)
1. Radiation-sensitive genetically susceptible pediatric sub-populations.
Kleinerman RA
Pediatr Radiol; 2009 Feb; 39 Suppl 1(Suppl 1):S27-31. PubMed ID: 19083227
[TBL] [Abstract][Full Text] [Related]
2. Bone and Soft-Tissue Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma Treated With Radiation.
Kleinerman RA; Schonfeld SJ; Sigel BS; Wong-Siegel JR; Gilbert ES; Abramson DH; Seddon JM; Tucker MA; Morton LM
J Clin Oncol; 2019 Dec; 37(35):3436-3445. PubMed ID: 31622129
[TBL] [Abstract][Full Text] [Related]
3. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up.
Kleinerman RA; Tucker MA; Tarone RE; Abramson DH; Seddon JM; Stovall M; Li FP; Fraumeni JF
J Clin Oncol; 2005 Apr; 23(10):2272-9. PubMed ID: 15800318
[TBL] [Abstract][Full Text] [Related]
4. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
[TBL] [Abstract][Full Text] [Related]
5. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk.
Wong FL; Boice JD; Abramson DH; Tarone RE; Kleinerman RA; Stovall M; Goldman MB; Seddon JM; Tarbell N; Fraumeni JF; Li FP
JAMA; 1997 Oct; 278(15):1262-7. PubMed ID: 9333268
[TBL] [Abstract][Full Text] [Related]
6. Lifetime risks of common cancers among retinoblastoma survivors.
Fletcher O; Easton D; Anderson K; Gilham C; Jay M; Peto J
J Natl Cancer Inst; 2004 Mar; 96(5):357-63. PubMed ID: 14996857
[TBL] [Abstract][Full Text] [Related]
7. Cancer incidence after retinoblastoma: radiation dose and sarcoma risk.
Murray T
Surv Ophthalmol; 1998; 43(3):288-9. PubMed ID: 9862317
[No Abstract] [Full Text] [Related]
8. Gene environment interactions in a cohort of irradiated retinoblastoma patients.
Kleinerman RA; Stovall M; Tarone RE; Tucker MA
Radiat Res; 2005 Jun; 163(6):701-2. PubMed ID: 16044502
[No Abstract] [Full Text] [Related]
9. Craniofacial second primary tumors in patients with germline retinoblastoma previously treated with external beam radiotherapy: A retrospective institutional analysis.
Jiménez I; Laé M; Tanguy ML; Savignoni A; Gauthier-Villars M; Desjardins L; Cassoux N; Dendale R; Rodriguez J; Doz F; Brisse HJ; Aerts I
Pediatr Blood Cancer; 2020 Apr; 67(4):e28158. PubMed ID: 31904159
[TBL] [Abstract][Full Text] [Related]
10. Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome.
Le AN; Harton J; Desai H; Powers J; Zelley K; Bradbury AR; Nathanson KL; Shah PD; Doucette A; Freedman GM; Gabriel P; Domchek SM; MacFarland SP; Maxwell KN
Breast Cancer Res Treat; 2020 May; 181(1):181-188. PubMed ID: 32246378
[TBL] [Abstract][Full Text] [Related]
11. Osteosarcoma following retinoblastoma: age at onset and latency period.
Chauveinc L; Mosseri V; Quintana E; Desjardins L; Schlienger P; Doz F; Dutrillaux B
Ophthalmic Genet; 2001 Jun; 22(2):77-88. PubMed ID: 11449317
[TBL] [Abstract][Full Text] [Related]
12. Familial neurogenic tumor syndromes.
Kimmelman A; Liang BC
Hematol Oncol Clin North Am; 2001 Dec; 15(6):1073-84. PubMed ID: 11770299
[TBL] [Abstract][Full Text] [Related]
13. Correlation between RB1germline mutations and second primary malignancies in hereditary retinoblastoma patients treated with external beam radiotherapy.
Chaussade A; Millot G; Wells C; Brisse H; Laé M; Savignoni A; Desjardins L; Dendale R; Doz F; Aerts I; Jimenez I; Cassoux N; Stoppa Lyonnet D; Gauthier Villars M; Houdayer C
Eur J Med Genet; 2019 Mar; 62(3):217-223. PubMed ID: 30031154
[TBL] [Abstract][Full Text] [Related]
14. [Genetic predisposition to cancer in children].
Brugieres L
Rev Prat; 2007 May; 57(10):1065-7. PubMed ID: 17899678
[No Abstract] [Full Text] [Related]
15. Second primary tumors in hereditary retinoblastoma: a register-based study, 1945-1997: is there an age effect on radiation-related risk?
Moll AC; Imhof SM; Schouten-Van Meeteren AY; Kuik DJ; Hofman P; Boers M
Ophthalmology; 2001 Jun; 108(6):1109-14. PubMed ID: 11382638
[TBL] [Abstract][Full Text] [Related]
16. Second primary tumours in hereditary- and nonhereditary retinoblastoma patients treated with megavoltage external beam irradiation.
Imhof SM; Moll AC; Hofman P; Mourits MP; Schipper J; Tan KE
Doc Ophthalmol; 1997; 93(4):337-44. PubMed ID: 9665291
[TBL] [Abstract][Full Text] [Related]
17. Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes.
Evans DG; Birch JM; Ramsden RT; Sharif S; Baser ME
J Med Genet; 2006 Apr; 43(4):289-94. PubMed ID: 16155191
[TBL] [Abstract][Full Text] [Related]
18. Second primary tumors in hereditary retinoblastoma.
Stevens KR
Ophthalmology; 2002 Nov; 109(11):1947; author reply 1947. PubMed ID: 12414381
[No Abstract] [Full Text] [Related]
19. Second nonocular tumors in survivors of heritable retinoblastoma and prior radiation therapy.
Mohney BG; Robertson DM; Schomberg PJ; Hodge DO
Am J Ophthalmol; 1998 Aug; 126(2):269-77. PubMed ID: 9727521
[TBL] [Abstract][Full Text] [Related]
20. Fibroblasts from patients with inherited predisposition to retinoblastoma exhibit normal sensitivity to the mutagenic effects of ionizing radiation.
Wang Y; Parks WC; Wigle JC; Maher VM; McCormick JJ
Mutat Res; 1986 Oct; 175(2):107-14. PubMed ID: 3762576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
